Geneva Capital Management
Geneva Capital Management reported 119 stocks worth $4.4B in its 13F filing for Q2 2026, filed Aug 6, 2026. Its largest holdings are RBC (4.4%), ONTO (4.2%) and ESE (3.6%). Compared with Q1 2026, the fund opened new positions in CR, added to LOAR, HEI.A and IWO, trimmed RBC, ONTO and ESE and sold out of CERT and FBIN.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  RBC RBC Bearings Inc | $191M | 4.4% | 296K | −87K (−23%) | 8 of 8 | |
| 2 |  ONTO Onto Innovation Inc | $184M | 4.2% | 487K | −219K (−31%) | 8 of 8 | |
| 3 |  ESE Esco Technologies Inc | $157M | 3.6% | 449K | −177K (−28%) | 8 of 8 | |
| 4 |  AAON Aaon Inc | $152M | 3.5% | 1.2M | −521K (−30%) | 8 of 8 | |
| 5 |  ROAD Construction Partners Inc | $148M | 3.4% | 1.2M | −317K (−20%) | 8 of 8 | |
| 6 |  NOVT Novanta Inc | $123M | 2.8% | 759K | −172K (−19%) | 8 of 8 | |
| 7 |  TXRH Texas Roadhouse Inc | $120M | 2.8% | 623K | −174K (−22%) | 8 of 8 | |
| 8 |  BCPC Balchem Corp | $115M | 2.6% | 683K | −163K (−19%) | 8 of 8 | |
| 9 |  GMED Globus Med Inc | $112M | 2.6% | 1.4M | −344K (−20%) | 8 of 8 | |
| 10 |  HQY Healthequity Inc | $104M | 2.4% | 1.1M | −24K (−2%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 6, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Geneva Capital Management 13F FAQ
What does Geneva Capital Management own?
Geneva Capital Management reported 119 stocks worth $4.4B in its 13F filing for Q2 2026, filed Aug 6, 2026. Its largest holdings are RBC (4.4%), ONTO (4.2%) and ESE (3.6%). The table above lists every position in the filing (the top 10 without an account).
What did Geneva Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 1 new positions, 14 added to, 103 trimmed and 2 sold out. New positions include CR. It sold all of CERT and FBIN.
When will Geneva Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Geneva Capital Management's portfolio worth?
The Q2 2026 filing reports $4.4B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.